AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05693922 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Single-session behavioral activation
Description: Participants will take part in a single-session behavioral activation (BA) intervention. This intervention was adapted from standard BA protocols for the treatment of depression to be completed in a single, 90-minute session. This intervention will have 4 main components based on prior protocols:~* Treatment overview and rationale~* Tracking of daily activities~* Exploration of values~* Planning/scheduling activities
Study NCT05693922 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Active sham cross-frequency transcranial alternating current stimulation via the NeuroConn DC-STIMULATOR MC
Description: Active sham stimulation will be delivered via the NeuroConn DC-STIMULATOR MC, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.
Study NCT04846140 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial electrical stimulation (tES)
Description: Transcranial electrical stimulation (tES) is a form of neuromodulation that uses constant, low direct current delivered via the electrodes on the skull. Three types of tES will be applied in this study, include a-tDCS, tACS, and tRNS. Additionally, sham stimulation will be applied as a placebo-controlled intervention.
Study NCT06214585 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intermittent heat and cold versus heat-only therapy
Description: for the experimental group, a cyclical method of alternating heat and cold application will be used on the lumbosacral and lower abdominal area of the laboring women. The process involves applying a hot pack with a temperature range of 38-40°C on their lower abdomen and low back for 30 minutes during contractions and a relaxing period using a 2-litre rubber hot water bag. Subsequently, reusable ice packs typically contain water, covered with a towel and with a temperature range of 0-5°C will be applied to the same areas for 10 minutes. After a 30-minute interval, the heat application will be reapplied, and this alternating heat and cold cycle will be repeated throughout the first stage of the laboring process.
Study NCT06214585 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Heat- only Therapy
Description: hot water bag will be used to provide heat to the lower back of primigravida women during the first stage of labor. The water in the bag will be maintained at a temperature of 40-42ºC. The application of heat will last for 20 minutes, and it will be repeated every hour until the cervix is fully dilated.
Study NCT05961202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Hydroxychloroquine 200mg qd
Study NCT05961202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: Prednisolone 20mg qd
Study NCT05961202 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone
Description: Prednisolone 20mg qd
Study NCT05038488 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: MIB-626
Description: Fifty participants will be randomized, stratified by sex, remdesivir use, and trial site, in a 3:2 ratio to receive either MIB-626 1.0 g orally or matching placebo twice daily for 14 days.
Study NCT05038488 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIB-626
Description: Fifty participants will be randomized, stratified by sex, remdesivir use, and trial site, in a 3:2 ratio to receive either MIB-626 1.0 g orally or matching placebo twice daily for 14 days.
Study NCT05038488 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Subjects will be randomized to receive either the placebo or 1000-mg MIB-626 twice daily orally.
Study NCT05038488 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will be randomized to receive either the placebo or 1000-mg MIB-626 twice daily orally.
Study NCT05038488 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Home Treatment
Description: Participants, who are discharged from the hospital before the completion of the 14-day intervention period, will be provided sufficient study medication to take home with them so they can continue to take the medication twice daily for the remaining duration of the 14-day intervention period.
Study NCT05905965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 20 mg
Description: Patients receiving empagliflozin 20 mg daily - experimental arm
Study NCT05905965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Empagliflozin 10 mg
Description: Patients receiving empagliflozin 10 mg daily - control arm
Study NCT05179954 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Metabolic testing
Description: Participants will complete a metabolic testing protocol that includes intravenous infusion of stable isotope labeled tracers and blood sampling to determine lipoprotein kinetics
Study NCT05179954 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Metabolic testing
Description: Participants will complete a metabolic testing protocol that includes intravenous infusion of stable isotope labeled tracers and blood sampling to determine lipoprotein kinetics
Study NCT05349669 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jafron use during CPB
Description: Use of filter Jafron during CPB
Study NCT05286905 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Osteosynthesis cephalomedullary nail
Description: Osteosynthesis of reverse oblique peritrochanteric fractures with cephalomedullary nail
Study NCT05286905 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Osteosynthesis proximal femur locking plate
Description: Osteosynthesis of reverse oblique peritrochanteric fractures with proximal femur locking plate
Study NCT04649892 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psychoeducational
Description: Participants will also attend to 4 sessions of psychoeducational intervention in weeks 2, 4, 6, and 8
Study NCT04649892 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Eye-tracking
Description: The attentional bias of the participants will be assessed using the Eye-tracking device in 4 moments throughout the study:~* Before taking the first dose of naltrexone or placebo.~* One hour after taking the first dose of naltrexone or placebo.~* One week after continuous and daily use of naltrexone or placebo.~* At the end of the intervention, after 12 weeks of continuous and daily use of naltrexone or placebo.
Study NCT04649892 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Eye-tracking
Description: The attentional bias of the participants will be assessed using the Eye-tracking device in 4 moments throughout the study:~* Before taking the first dose of naltrexone or placebo.~* One hour after taking the first dose of naltrexone or placebo.~* One week after continuous and daily use of naltrexone or placebo.~* At the end of the intervention, after 12 weeks of continuous and daily use of naltrexone or placebo.
Study NCT05187455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Each patient received a single dose administration of sugammadex 2mg/kg at reappearance of the second twitch of the train-of-four (TOF).
Study NCT06202885 — intervention group
Intervention type: DRUG
Intervention: Immunotherapy
Description: Immunotherapy
Study NCT05168319 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation
Description: Participants received 10HZ rTMS protocol consisted of 5 sessions over 5 consecutive workdays
Study NCT05168319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Description: Participants received pcTBS protocol consisted of 5 sessions over 5 consecutive workdays
Study NCT05168319 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: Participants received Sham rTMS stimulations consisted of 5 sessions over 5 consecutive workdays
Study NCT05831852 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT06535698 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Perelel Health Hormonal Balance Support
Description: The supplement contains Myo-inositol (1000 mcg), Metabolic balance blend (200 mcg) including Berberine HCl, Alpha lipoic acid, DIM (33'-Diindolylmethane), and D-chiro-inositol (25 mg). Other ingredients include Vegetable cellulose (capsule), plant cellulose, and L-leucine.
Study NCT06534697 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naropin, 0.2% Injectable Solution in Sodium chloride
Description: Preoperative fascia iliaca block with 40 ml volume of naropin 0,25% in sodium chloride
Study NCT06534697 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naropin, 0.2% Injectable Solution in dextrose 5%
Description: Preoperative fascia iliaca block with 40 ml volume of naropin 0,25% in dextrose 5%
Study NCT06534697 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dextrose 10 % in Water
Description: Preoperative fascia iliaca block with 40 ml volume of dextrose 10%
Study NCT05447169 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EBV antibodies test
Description: ELISA test of VCA-IgA，EBNA1-IgA，EA-IgA， Zta-IgA ，Rta-IgG and BNLF 2b in nasopharyngeal brushing and plasma
Study NCT05447169 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EBV DNA test
Description: quantitative polymerase chain reaction, CRISPR-associated protein 12a and target sequencing of EBV DNA in nasopharyngeal brushing and plasma
Study NCT05491733 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: APX001
Description: Low-load oral tablet
Study NCT05491733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APX001
Description: Low-load oral tablet
Study NCT05491733 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: APX001A
Description: High-load oral tablet
Study NCT05491733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APX001A
Description: High-load oral tablet
Study NCT06534606 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electrotherapy and physical agents
Description: Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.~• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
Study NCT06534606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrotherapy and physical agents
Description: Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.~• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
Study NCT06534606 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Headache SNAGs
Description: Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.~• Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Study NCT06534606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Headache SNAGs
Description: Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.~• Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Study NCT06534606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sternocleidomastoid Release
Description: Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Study NCT06227494 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fiber Intervention
Description: Group education and phone-based motivational interviewing to gradually increase dietary fiber consumption to 30-35 grams per day.
Study NCT06227494 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Weight Loss Education
Description: Group education and phone-based motivational interviewing to promote current evidence-based behaviors to promote weight loss via achieving a negative energy balance.
Study NCT06227494 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Weight Loss Education
Description: Group education and phone-based motivational interviewing to promote current evidence-based behaviors to promote weight loss via achieving a negative energy balance.
Study NCT04393831 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Retzius sparing
Description: Retzius nerve sparing is a specific approach that avoids disrupting the structures involved in urinary and sexual function.
Study NCT06540924 — intervention group
Intervention type: OTHER
Intervention: single nucleotide polymorphisms
Description: The LBX1 (Ladybird Homeobox 1), TIMP2 (Tissue Inhibitor of Metalloprotease 2), GPR126 (G Protein-Coupled Receptor 126) and CHD7 (Chromodomain Helicase DNA Binding Protein 7) gene polymorphisms in adolescent idiopathic scoliosis patients and the control group were analyzed using real-time PCR with TaqMan probe SNP (single nucleotide polymorphism) primers (rs625039, rs11598564, rs6570507, rs121434341, rs11190870, rs8179090).
Study NCT05071417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Usual treatment with semaglutide. Dose 0.5 - 1mg weekly, subcutaneous, weekly
Study NCT05253703 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual reality bicycling
Description: This is a single arm study in which all participants will execute the same three bicycling tasks over one session (see arm/group description).
Study NCT05281692 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Enhanced Preservation Media (EPM-IX)
Description: EPM-IX is a clinical specimen collection medium that inactivates pathogens, preserves nucleic acids, and integrates DNA/RNA purification. EPM-IX eliminates the need for additional extraction reagents or kits and purifies DNA/ RNA from the entire sample to enable optimal test performance.
Study NCT06522451 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physical therapy
Description: Only conventional physical therapy (CPT) will be administered to this group. These regular workouts will include dynamic and static stretching, walking-specific functional exercises, passive mobilizations for pain-free mobility, balance modulation, and gait training. At baseline, the functional state of both groups will be evaluated. Treatment sessions will run for a total of 12 weeks, five days a week, for 45 minutes each. They will consist of four to six repeated exercises, six times on average, and use BSID-4 once the trial is over.
Study NCT06522451 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy along with cuevas medek exercises
Description: In addition to regular physical therapy, this group will get Cuevas Medak exercises including head and trunk control (by stabilizing limb) and standing to sitting transition. For a duration of 12 weeks, five days a week, and 45 minutes, each session will be held. At the baseline, the functional state of both groups will be evaluated.
Study NCT05576467 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MBCT-Telephone
Description: Classes follow MBCT protocol delivered via telephone by a master's level or higher mental health provider under the supervision of a licensed clinical psychologist, following treatment fidelity guidelines from NIH's Behavioral Change Consortium.
Study NCT05576467 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MBCT-Video
Description: Classes follow MBCT protocol delivered via video by a master's level or higher mental health provider under the supervision of a licensed clinical psychologist, following treatment fidelity guidelines from NIH's Behavioral Change Consortium.
Study NCT06416943 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D printed educational model
Description: Slide-based presention plus 3D printed port-A catheter model
Study NCT05066425 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Soluble Corn Fiber
Description: Participants will be asked to consume a packet of 22g Soluble Corn Fiber/day for 4 weeks
Study NCT05066425 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Participants will be asked to consume a packet of 22g Maltodextrin/day for 4 weeks
Study NCT06155344 — intervention group
Intervention type: OTHER
Intervention: Food Frequency Questionnaire
Description: We will obtain a global index of vegetalization of the diet (the Plant based Diet Index: PDI) from data obtained using semi-quantitative questionnaires on food frequency (Food Frequency Questionnaire (FFQ)) validated on the national ELFE cohort (French Longitudinal Study from Childhood (https://www.elfe-france.fr)) and completed by women in the 1st trimester of pregnancy (T1) and at delivery.
Study NCT06155344 — intervention group
Intervention type: OTHER
Intervention: Collection of 4 mL maternal blood
Description: One tube collection of 4 mL maternal blood in the first trimester and at delivery.
Study NCT05714592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: The referring haematologist will suggest that the patient participate in the study during the consultation. In these patients, the investigators will perform OGM on the cytogenetic sample
Study NCT06039501 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Perspective Program
Description: The program involves regular meetings between families and an ICU support counselor. The ICU support counselor is a trained expert in providing culturally competent emotional and/or spiritual support. The ICU support counselor will support families and also learn and summarize family perspectives in a standardized report. ICU care team members will be prompted to perspective take as they review reports prior to regular routine meetings between families and the ICU care team.
Study NCT04165746 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foster Care
Description: Upon entry into the Child Protection System, if the child is assigned to one of the districts participating in the RCT, the court will notify the study team. Children that have been randomly assigned to Foster Care will be placed in a foster home within 48 hours of referral to the Family Court/Child Protection System.~Children and Foster Parents will receive biweekly visits from Social Workers. Children and Foster parents will also participate in the caregiving intervention described below. Children will remain in the placement until such time as the social workers, psychologists and Family Court Judge determine that one of the following outcomes is appropriate: reunification with biological family or adoption.
Study NCT04165746 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Caregiving Intervention
Description: During AVI an intervenor meets with a caregiver (foster parent or caregiver at the institution) and child in the home environment. During each session, the intervenor videotapes the caregiver and child doing play-based activities. During that meeting, the intervenor reviews the videos with the caregiver and provides positive, constructive feedback to the caregiver. AVI is aimed at increasing sensitivity in parents/caregivers in order to encourage positive interactions. The guiding principles are to create a positive environment and to convey that the caregiver is the expert on their own child. The AVI methodology was selected to be used as a method of caregiving intervention with the study participants due to its demonstrated results in its use with children in contexts of social vulnerability, as well as families included in the child protection system. This will be the first time that AVI is being used in foster and institutional care in Brazil.
Study NCT04629495 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rapamycin
Description: RAPA will be administered orally 1mg daily
Study NCT04629495 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered orally once daily
Study NCT04944043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQ05105 Tablet
Description: TQ05105 tablet is a Janus Kinase (JAK) inhibitor, which can inhibit the abnormal activation of JAK 2-V617F mutation, thereby inhibiting the sustained abnormal activation of JAK / STAT pathway.
Study NCT05595967 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health education intervention
Description: Both the two session contains modules focusing on heath related knowledge and pelvic floor muscle exercise. Both two session will be delivered by primary healthcare women workers in small groups (about 20 women per group). The local healthcare workers are responsible for making appointment with each participant through group activities. Each participant will receive a healthy calendar practice to record the number of exercises per day which will be supervised by primary healthcare workers. All healthcare workers are required to attend a full-day workshop organized base on the scheme and teaching materials developed by our research team. The contents of the workshop include: (1) introduction of pelvic floor dysfunction; (2) risk factors and prevention of pelvic floor dysfunction; (3) kegel movement; (4) methods of dealing with severe illness; (5) a standard procedure of group activities or one-on-one activities; (6) skills needed for the delivery of health education intervention.
Study NCT05265286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FRSW117
Description: Subjects of high dose group are being received four doses(50 IU/kg,once a week or every 7 days) of FRSW117.~Subjects of low dose group (40 IU/kg,once a week or every 7 days)are being received four doses of FRSW117.
Study NCT05346939 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dynamic taping
Description: The athletic trainer will intervene with spiral dynamic technique by using a dynamic tape for the first test and a sham dynamic tape for the second test, or reverse the order.